The COVID-19 pandemic has deeply and globally impacted usual procedures and patients management in cancer centers. The aim of this study is to set-up and collect indicators to follow-up the activities of different cancer pathologies before and during the pandemic. Patients loss' of chance will be analysed in term of diagnosis and access to care (surgery, antineoplastic treatments). Data collection will focus on the analysis of 2 specific pathologies for French patients in the "Auvergne-Rhône Alpes" Area: peritoneal carcinosis and hepatocellular carcinoma.
Study Type
OBSERVATIONAL
Enrollment
4,000
The following items will be collected * Diagnostic date * Diagnostic stage * Date of surgery * Date of surgery appointment * First antineoplastic treatment date * Last antineoplastic treatment date * Number of treatment cycles recommanded by MDTM
Hopital Lyon sud, Hospices civils de Lyon
Pierre-Bénite, France
RECRUITINGMeasure of patient loss of chance when comparing a set of activity indicators between 2020 and the average activities of previous periods (2017-2019)
The difference between a set of different activity indicators will be compared between 2020 and the average activities of previous periods (2017-2019)
Time frame: 24 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.